216 related articles for article (PubMed ID: 8877030)
1. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
[TBL] [Abstract][Full Text] [Related]
2. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
4. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
6. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
Fjellestad A; Czernichow P
Acta Paediatr Scand; 1986 Jul; 75(4):605-10. PubMed ID: 3529809
[TBL] [Abstract][Full Text] [Related]
7. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
Fukuda I; Hizuka N; Takano K
Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
[TBL] [Abstract][Full Text] [Related]
8. Water-balance hormones during long-term follow-up of oral dDAVP treatment in diabetes insipidus.
Fjellestad-Paulsen A; Laborde K; Kindermans C; Czernichow P
Acta Paediatr; 1993 Sep; 82(9):752-7. PubMed ID: 8241672
[TBL] [Abstract][Full Text] [Related]
9. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
10. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
Kinter LB; Beeuwkes R
Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
[TBL] [Abstract][Full Text] [Related]
12. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
Blackett PR; Seely JR; Altmiller DH; Males JL
Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
[TBL] [Abstract][Full Text] [Related]
13. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
Moses AM; Scheinman SJ; Schroeder ET
Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
[TBL] [Abstract][Full Text] [Related]
14. Oral desmopressin treatment of central diabetes insipidus in children.
Boulgourdjian EM; Martínez AS; Ropelato MG; Heinrich JJ; Bergadá C
Acta Paediatr; 1997 Nov; 86(11):1261-2. PubMed ID: 9401525
[TBL] [Abstract][Full Text] [Related]
15. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
Laczi F; Mezei G; Julesz J; Lázló FA
Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
Radó JP; Marosi J; Fischer J; Takó J; Kiss N
Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
18. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
Hammer M; Vilhardt H
J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
[TBL] [Abstract][Full Text] [Related]
19. DDAVP in the treatment of central diabetes insipidus.
Robinson AG
N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
[TBL] [Abstract][Full Text] [Related]
20. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
Czakó L; Mezei G; László FA
Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
